Caplin Point Laboratories (NSE:CAPLIPOINT) Tax Expense: ₹1,531 Mil (TTM As of Mar. 2026)


NSE:CAPLIPOINT Caplin Point Laboratories Ltd NSE:CAPLIPOINT
92 GF Score
Price ₹2,538.10
GF Value ₹2,082.30
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Caplin Point Laboratories Tax Expense?

Caplin Point Laboratories NSE:CAPLIPOINT 92 Tax Expense is ₹1,531 Mil as of Mar. 2026. GuruFocus rates NSE:CAPLIPOINT with a GF Score™ of 92/100 and a GF Value™ of ₹2,082.30 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Caplin Point Laboratories's tax expense for the months ended in Mar. 2026 was ₹406 Mil. Its tax expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1,531 Mil.


Caplin Point Laboratories  (NSE:CAPLIPOINT) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Caplin Point Laboratories Tax Expense Related Terms


Caplin Point Laboratories Tax Expense Historical Data

* Premium members only.

The historical data trend for Caplin Point Laboratories's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Caplin Point Laboratories Tax Expense Chart

Caplin Point Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 773.70 743.60 1,030.10 1,356.90 1,530.60

Caplin Point Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 313.90 337.00 407.70 380.30 405.60
NSE:CAPLIPOINT
92GF Score
Caplin Point Laboratories Ltd NSE:CAPLIPOINT
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Caplin Point Laboratories Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,531 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of ₹1,531 Mil mean?
Caplin Point Laboratories (NSE:CAPLIPOINT) has a Tax Expense of ₹1,531 Mil as of Mar. 2026. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Caplin Point Laboratories and its competitors.
Is Caplin Point Laboratories' Tax Expense too high?
Caplin Point Laboratories' current Tax Expense is ₹1,531 Mil. Overall, Caplin Point Laboratories has a GF Score™ of 92/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Caplin Point Laboratories' Tax Expense compare to ZTS and UTHR?
Caplin Point Laboratories' Tax Expense of ₹1,531 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Drug Manufacturers company?
A good Tax Expense depends on the Drug Manufacturers industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Caplin Point Laboratories and its competitors. Caplin Point Laboratories's current Tax Expense is ₹1,531 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caplin Point Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Caplin Point Laboratories (NSE:CAPLIPOINT) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹2,082.30, compared to a current price of ₹2,538.10 — trading 21.9% above its estimated fair value. The current Tax Expense is ₹1,531 Mil. Caplin Point Laboratories' overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For Caplin Point Laboratories (NSE:CAPLIPOINT), the current Tax Expense is ₹1,531 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Caplin Point Laboratories (NSE:CAPLIPOINT) Overvalued in 2026?

Based on GuruFocus' analysis, Caplin Point Laboratories stock appears to be overvalued. The current stock price of ₹2,538.10 is trading 21.9% above its estimated GF Value™ of ₹2,082.30. GuruFocus considers Caplin Point Laboratories to be Modestly Overvalued.

Key valuation signals for NSE:CAPLIPOINT:

  • Tax Expense: ₹1,531 Mil
  • GF Value™: ₹2,082.30 vs. price of ₹2,538.10 (21.9% above fair value)
  • GF Score™: 92/100 with 5 warning signs

No single metric tells the full story. See the NSE:CAPLIPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Caplin Point Laboratories Business Description

Other Exchanges 524742:India
Address Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096
Caplin Point Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, injections (liquid and lyophilized, prefilled syringes), ophthalmic solutions, liquid orals, soft gel capsules, ointments, creams, gels, powders for injections, suppositories, ovules, pre-mix bag formulations, inhalers, sprays, and IV infusions. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops.
92GF Score

Get the complete analysis for NSE:CAPLIPOINT

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,538.10
Price
₹2,082.30
GF Value